ee

Registreeru
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele.

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

Kodu・Aktsiate loetelu・AstraZeneca PLC ADR
Search

AstraZeneca PLC ADR

Suletud

77.42 -1.06

Tugev "osta" hinnang

Hinna uuendus 21. okt 2024, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

77.36

Max

78.25

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+17.74 upside

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

77.47 / 78.305 Toetus ja vastupanu

AstraZeneca PLC ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. sept 2024, 09:29 UTC

Suurimad hinnamuutused turgudel

AstraZeneca Shares Slump After Cancer Drug Misses Key Target

DJ

Loe

25. juuli 2024, 09:17 UTC

Tulu

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

DJ

Loe

25. juuli 2024, 06:48 UTC

Tulu

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

DJ

Loe

12. sept 2024, 17:01 UTC

Peamised uudised

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

DJ

Loe

12. sept 2024, 11:00 UTC

Peamised uudised

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

DJ

Loe

10. sept 2024, 13:08 UTC

Market Talk

AstraZeneca's Lung Cancer Drug Candidate Disappoints, Lowering Probability of FDA Approval -- Market Talk

DJ

Loe

9. sept 2024, 07:56 UTC

Market Talk

Big Pharma's Stability in Return on R&D Investment Is Encouraging -- Market Talk

DJ

Loe

5. sept 2024, 13:00 UTC

Peamised uudised

China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ

DJ

Loe

29. juuli 2024, 10:30 UTC

Peamised uudised

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

DJ

Loe

25. juuli 2024, 13:20 UTC

Tulu

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

DJ

Loe

25. juuli 2024, 09:21 UTC

Market Talk
Tulu

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

DJ

Loe

25. juuli 2024, 07:05 UTC

Market Talk
Tulu

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

DJ

Loe

25. juuli 2024, 06:06 UTC

Tulu

AstraZeneca Increased Interim Dividend by 7c to $1.00

DJ

Loe

25. juuli 2024, 06:04 UTC

Tulu

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

DJ

Loe

25. juuli 2024, 06:04 UTC

Tulu

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

DJ

Loe

25. juuli 2024, 06:04 UTC

Tulu

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

DJ

Loe

25. juuli 2024, 06:04 UTC

Tulu

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

DJ

Loe

25. juuli 2024, 06:03 UTC

Tulu

AstraZeneca Raises 2024 View

DJ

Loe

25. juuli 2024, 06:02 UTC

Tulu

AstraZeneca 2Q Revenue Consensus Was $12.7B

DJ

Loe

25. juuli 2024, 06:02 UTC

Tulu

AstraZeneca 2Q Core EPS Consensus Was $1.95

DJ

Loe

25. juuli 2024, 06:00 UTC

Tulu

AstraZeneca PLC 2Q Adj EPS $1.98

DJ

Loe

25. juuli 2024, 06:00 UTC

Tulu

AstraZeneca PLC 2Q Pretax Pft $2.4B

DJ

Loe

25. juuli 2024, 06:00 UTC

Tulu

AstraZeneca PLC 2Q Rev $12.94B

DJ

Loe

25. juuli 2024, 06:00 UTC

Tulu

AstraZeneca PLC 2Q Oper Pft $2.75B

DJ

Loe

25. juuli 2024, 06:00 UTC

Tulu

AstraZeneca PLC 2Q Net Pft $1.93B

DJ

Loe

25. juuli 2024, 06:00 UTC

Tulu

AstraZeneca PLC 2Q EPS $1.24

DJ

Loe

15. juuli 2024, 06:04 UTC

Omandamised, ülevõtmised, äriostud

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

DJ

Loe

15. juuli 2024, 06:04 UTC

Omandamised, ülevõtmised, äriostud

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

DJ

Loe

15. juuli 2024, 06:02 UTC

Omandamised, ülevõtmised, äriostud

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

DJ

Loe

15. juuli 2024, 06:02 UTC

Omandamised, ülevõtmised, äriostud

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

AstraZeneca PLC ADR Prognoos

Hinnasiht

By TipRanks

17.74% tõus

12 kuu keskmine prognoos

Keskmine 92.14 USD  17.74%

Kõrge 99 USD

Madal 86 USD

Põhineb 6 Wall Streeti analüütiku instrumendi AstraZeneca PLC ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

5

Osta

1

Hoia

0

Müü

Põhineb 6 analüütiku instrumendi AstraZeneca PLC ADR aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

77.47 / 78.305Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Strong Bearish Evidence

Bearish events outweigh bullish events.

Pikk perspektiiv

No Evidence

There are no events.

Finantsandmed

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

905.59

↓-1.35%

UNH

UnitedHealth Group Inc

570.56

↑ +0.14%

NVO

Novo Nordisk A-S

117.32

↓-0.78%

JNJ

Johnson and Johnson

162.66

↓-1.43%

ABBV

AbbVie Inc

186.25

↓-1.36%